-
1دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Manolika, M., Zafiriou, E., Sarafidou, T., Bagiatis, V., Krüger-Krasagaki, S., Tosca, A., Patsatsi, A., Sotiriadis, D., Mamuris, Z., Roussaki-Schulze, A.
مصطلحات موضوعية: adalimumab, etanercept, genomic DNA, infliximab, tumor necrosis factor, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, adult, article, cohort analysis, disease duration, disease severity, female, genetic polymorphism, Greece, haplotype, human, major clinical study, male, pharmacogenetics, polymerase chain reaction, population genetics, priority journal, psoriasis, Psoriasis Area and Severity Index, Psoriasis Severity Index, restriction fragment length polymorphism, scoring system, single nucleotide polymorphism, treatment response
-
2دورية أكاديمية
المؤلفون: Vasilopoulos, Y., Bagiatis, V., Stamatopoulou, D., Zisopoulos, D., Alexiou, I., Sarafidou, T., Settas, L., Sakkas, L., Mamuris, Z.
مصطلحات موضوعية: Anti-CCP, Anti-TNF, Association, Pharmacogenetics, Polymorphism, adalimumab, cyclic citrullinated peptide antibody, etanercept, infliximab, leflunomide, methotrexate, rheumatoid factor, tumor necrosis factor inhibitor, antirheumatic agent, autoantibody, biological marker, cyclic citrullinated peptide, cyclopeptide, TNFRSF1A protein, human, TNFRSF1B protein, tumor necrosis factor alpha, tumor necrosis factor receptor 1, tumor necrosis factor receptor 2, adult, aged, allele, article, cohort analysis, controlled study